AZERION GROUP N.V. (AZRN.AS) Fundamental Analysis & Valuation

AMS:AZRN • NL00150006Z9

Current stock price

0.688 EUR
-0.01 (-1.99%)
Last:

This AZRN.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. AZRN.AS Profitability Analysis

1.1 Basic Checks

  • AZRN had negative earnings in the past year.
  • In the past year AZRN had a positive cash flow from operations.
  • In the past 5 years AZRN reported 4 times negative net income.
  • Of the past 5 years AZRN 4 years had a positive operating cash flow.
AZRN.AS Yearly Net Income VS EBIT VS OCF VS FCFAZRN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 -50M -100M

1.2 Ratios

  • With a Return On Assets value of -5.95%, AZRN is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
  • The Return On Equity of AZRN (-235.37%) is worse than 71.43% of its industry peers.
Industry RankSector Rank
ROA -5.95%
ROE -235.37%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AZRN.AS Yearly ROA, ROE, ROICAZRN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 100 -100

1.3 Margins

  • AZRN has a worse Gross Margin (27.61%) than 85.71% of its industry peers.
  • In the last couple of years the Gross Margin of AZRN has declined.
  • AZRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.75%
GM growth 5YN/A
AZRN.AS Yearly Profit, Operating, Gross MarginsAZRN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. AZRN.AS Health Analysis

2.1 Basic Checks

  • AZRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • AZRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AZRN.AS Yearly Shares OutstandingAZRN.AS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
AZRN.AS Yearly Total Debt VS Total AssetsAZRN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • AZRN has an Altman-Z score of 0.53. This is a bad value and indicates that AZRN is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.53, AZRN is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 15.07 is on the high side and indicates that AZRN has dependencies on debt financing.
  • AZRN has a worse Debt to Equity ratio (15.07) than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 15.07
Debt/FCF N/A
Altman-Z 0.53
ROIC/WACCN/A
WACC15.08%
AZRN.AS Yearly LT Debt VS Equity VS FCFAZRN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • A Current Ratio of 0.74 indicates that AZRN may have some problems paying its short term obligations.
  • AZRN has a worse Current ratio (0.74) than 80.95% of its industry peers.
  • AZRN has a Quick Ratio of 0.74. This is a bad value and indicates that AZRN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of AZRN (0.74) is worse than 80.95% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.74
AZRN.AS Yearly Current Assets VS Current LiabilitesAZRN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AZRN.AS Growth Analysis

3.1 Past

  • AZRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.39%, which is quite impressive.
  • Looking at the last year, AZRN shows a small growth in Revenue. The Revenue has grown by 0.33% in the last year.
  • AZRN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.10% yearly.
EPS 1Y (TTM)43.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.27%
Revenue 1Y (TTM)0.33%
Revenue growth 3Y6.1%
Revenue growth 5YN/A
Sales Q2Q%0.89%

3.2 Future

  • Based on estimates for the next years, AZRN will show a very strong growth in Earnings Per Share. The EPS will grow by 22.47% on average per year.
  • Based on estimates for the next years, AZRN will show a small growth in Revenue. The Revenue will grow by 7.48% on average per year.
EPS Next Y0%
EPS Next 2Y22.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.43%
Revenue Next 2Y7.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AZRN.AS Yearly Revenue VS EstimatesAZRN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 200M 400M 600M
AZRN.AS Yearly EPS VS EstimatesAZRN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

4

4. AZRN.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • AZRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 3.37, which indicates a rather cheap valuation of AZRN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AZRN indicates a rather cheap valuation: AZRN is cheaper than 100.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, AZRN is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 3.37
AZRN.AS Price Earnings VS Forward Price EarningsAZRN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AZRN indicates a rather cheap valuation: AZRN is cheaper than 85.71% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.09
AZRN.AS Per share dataAZRN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • AZRN's earnings are expected to grow with 22.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.47%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AZRN.AS Dividend Analysis

5.1 Amount

  • AZRN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AZRN.AS Fundamentals: All Metrics, Ratios and Statistics

AZERION GROUP N.V.

AMS:AZRN (3/31/2026, 5:18:19 PM)

0.688

-0.01 (-1.99%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)02-26
Earnings (Next)05-28
Inst Owners0.02%
Inst Owner ChangeN/A
Ins Owners39.46%
Ins Owner ChangeN/A
Market Cap84.53M
Revenue(TTM)553.00M
Net Income(TTM)-34.60M
Analysts82.86
Price Target2.04 (196.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.37
P/S 0.15
P/FCF N/A
P/OCF 7.68
P/B 5.75
P/tB N/A
EV/EBITDA 6.09
EPS(TTM)-0.27
EYN/A
EPS(NY)0.2
Fwd EY29.65%
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)0.09
OCFY13.01%
SpS4.5
BVpS0.12
TBVpS-2.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.95%
ROE -235.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.61%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.75%
GM growth 5YN/A
F-Score5
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 15.07
Debt/FCF N/A
Debt/EBITDA 5.21
Cap/Depr 44.75%
Cap/Sales 3.85%
Interest Coverage N/A
Cash Conversion 25.88%
Profit Quality N/A
Current Ratio 0.74
Quick Ratio 0.74
Altman-Z 0.53
F-Score5
WACC15.08%
ROIC/WACCN/A
Cap/Depr(3y)47.24%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.18%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.27%
EPS Next Y0%
EPS Next 2Y22.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.33%
Revenue growth 3Y6.1%
Revenue growth 5YN/A
Sales Q2Q%0.89%
Revenue Next Year7.43%
Revenue Next 2Y7.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y79.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.86%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y20.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.03%
OCF growth 3Y-37.43%
OCF growth 5YN/A

AZERION GROUP N.V. / AZRN.AS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AZERION GROUP N.V.?

ChartMill assigns a fundamental rating of 2 / 10 to AZRN.AS.


Can you provide the valuation status for AZERION GROUP N.V.?

ChartMill assigns a valuation rating of 4 / 10 to AZERION GROUP N.V. (AZRN.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for AZERION GROUP N.V.?

AZERION GROUP N.V. (AZRN.AS) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for AZRN stock?

The Earnings per Share (EPS) of AZERION GROUP N.V. (AZRN.AS) is expected to decline by 0% in the next year.